Featured Posts
JAMA Study on Price of Diabetes Medicines is Deceiving and Threatens Medical Innovation
In a recent study by the activist-funded JAMA Network, researchers erroneously “determined” that the price of diabetes medicines, like insulins, SGLT2 inhibitors, and…
Commentary
Biden Budget Would Expand Devastating Drug Price Controls
President Biden’s new proposed budget for Fiscal Year 2025 calls for an expansion of the drug price controls passed in the Inflation Reduction Act (IRA). These…
Commentary
ATR Supports Bipartisan Bill that Expands Health Savings Accounts
In February, the House of Representatives placed H.R.5688, the Bipartisan HSA Improvement Act, on the Union Calendar making it eligible for floor consideration. This recent movement…
Commentary
Filtered Posts
Biden’s Inflation Reduction Act Was Never Intended to Reduce Inflation
Commentary
Biden Administration Announces Drugs Subject to Dangerous Price Controls
Commentary
Even Before Implementation, Democrats’ Price Control Policies are Inhibiting Medical Innovation
Commentary
ATR Submits Comments Opposing Proposed Price Controls in PAHPA
Commentary
Democrats’ SMART Prices Act Would Eliminate 237 New Pharmaceutical Treatments and Cut Over One Million Jobs
Commentary
The Organ Donation Clarification Act Would Save Lives and Money
Commentary
Congress Should Reject Efforts to Undermine the Contact Lens Rule
Commentary
Major Victories You May Have Missed From South Carolina This Year
Commentary
Democrats’ “SMART Prices Act” Would Expand Dangerous Price Controls on Medicine
Commentary
ATR Submits Comments Urging USITC to Recommend Against TRIPS Waiver Expansion
Commentary